Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.

Fiorini A, Koudriavtseva T, Bucaj E, Coccia R, Foppoli C, Giorgi A, Schininà ME, Di Domenico F, De Marco F, Perluigi M.

PLoS One. 2013 Jun 7;8(6):e65184. doi: 10.1371/journal.pone.0065184. Print 2013.

2.

Peripheral oxidative stress in relapsing-remitting multiple sclerosis.

Tasset I, Agüera E, Sánchez-López F, Feijóo M, Giraldo AI, Cruz AH, Gascón F, Túnez I.

Clin Biochem. 2012 Apr;45(6):440-4. doi: 10.1016/j.clinbiochem.2012.01.023. Epub 2012 Feb 4.

PMID:
22330938
3.

The clinical potential of blood-proteomics in multiple sclerosis.

De Masi R, Pasca S, Scarpello R, Idolo A, De Donno A.

BMC Neurol. 2013 May 21;13:45. doi: 10.1186/1471-2377-13-45.

4.

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

Teunissen CE, Koel-Simmelink MJ, Pham TV, Knol JC, Khalil M, Trentini A, Killestein J, Nielsen J, Vrenken H, Popescu V, Dijkstra CD, Jimenez CR.

Mult Scler. 2011 Jul;17(7):838-50. doi: 10.1177/1352458511399614. Epub 2011 Apr 19.

PMID:
21505015
5.

Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis.

Sawai S, Umemura H, Mori M, Satoh M, Hayakawa S, Kodera Y, Tomonaga T, Kuwabara S, Nomura F.

J Neuroimmunol. 2010 Jan 25;218(1-2):112-5. doi: 10.1016/j.jneuroim.2009.10.019. Epub 2009 Nov 17.

PMID:
19923011
6.

CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.

Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, Palm C, Hirt V, Suessmuth SD, Sapunova-Meier I, Ludolph AC, Brettschneider J.

Neurosci Lett. 2009 Mar 13;452(2):214-7. doi: 10.1016/j.neulet.2009.01.057. Epub 2009 Jan 29.

PMID:
19383442
7.

Cerebrospinal fluid proteome profile in multiple sclerosis.

Lehmensiek V, Süssmuth SD, Tauscher G, Brettschneider J, Felk S, Gillardon F, Tumani H.

Mult Scler. 2007 Aug;13(7):840-9.

PMID:
17881397
8.
9.

Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale.

Oliveira SR, Kallaur AP, Simão AN, Morimoto HK, Lopes J, Panis C, Petenucci DL, da Silva E, Cecchini R, Kaimen-Maciel DR, Reiche EM.

J Neurol Sci. 2012 Oct 15;321(1-2):49-53. doi: 10.1016/j.jns.2012.07.045. Epub 2012 Aug 9.

PMID:
22883481
10.

Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation.

Perluigi M, Giorgi A, Blarzino C, De Marco F, Foppoli C, Di Domenico F, Butterfield DA, Schininà ME, Cini C, Coccia R.

J Cell Mol Med. 2009 Aug;13(8B):1809-22. doi: 10.1111/j.1582-4934.2008.00465.x.

11.

Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.

Komori M, Matsuyama Y, Nirasawa T, Thiele H, Becker M, Alexandrov T, Saida T, Tanaka M, Matsuo H, Tomimoto H, Takahashi R, Tashiro K, Ikegawa M, Kondo T.

Ann Neurol. 2012 May;71(5):614-23. doi: 10.1002/ana.22633.

PMID:
22522477
12.

The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.

Abo-Krysha N, Rashed L.

Mult Scler. 2008 Jun;14(5):602-8. doi: 10.1177/1352458507085550. Epub 2008 Apr 11.

PMID:
18408021
13.

Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics.

Wen Q, Zhang L, Mao HP, Tang XQ, Rong R, Fan JJ, Yu XQ.

Biochem Biophys Res Commun. 2013 Aug 30;438(3):473-8. doi: 10.1016/j.bbrc.2013.07.116. Epub 2013 Aug 2.

PMID:
23916703
14.
15.

[Serum proteomic variation study in patients with Crohn disease].

Kang L, Yang ZL, Liu W, Zhang LJ, Liu SJ, Huang MJ, Li MT, Wang JP.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 May;11(3):266-9. Chinese.

PMID:
18478474
16.

Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.

Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A.

Hum Mol Genet. 2011 Sep 15;20(18):3606-19. doi: 10.1093/hmg/ddr281. Epub 2011 Jun 15.

PMID:
21676896
17.

Alteration of DBP levels in CSF of patients with MS by proteomics analysis.

Qin Z, Qin Y, Liu S.

Cell Mol Neurobiol. 2009 Mar;29(2):203-10. doi: 10.1007/s10571-008-9312-z. Epub 2008 Sep 19.

PMID:
18807170
18.

Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls.

Liu J, Yin L, Dong H, Xu E, Zhang L, Qiao Y, Liu Y, Li L, Jia J.

J Neuroimmunol. 2012 Sep 15;250(1-2):71-6. doi: 10.1016/j.jneuroim.2012.05.002. Epub 2012 May 24.

PMID:
22633274
19.

Comparative serum proteome expression of osteonecrosis of the femoral head in adults.

Wu RW, Wang FS, Ko JY, Wang CJ, Wu SL.

Bone. 2008 Sep;43(3):561-6. doi: 10.1016/j.bone.2008.04.019. Epub 2008 May 7.

PMID:
18572010
20.

Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis.

Ortiz GG, Macías-Islas MA, Pacheco-Moisés FP, Cruz-Ramos JA, Sustersik S, Barba EA, Aguayo A.

Dis Markers. 2009;26(1):35-9. doi: 10.3233/DMA-2009-0602.

Supplemental Content

Support Center